Search results
New studies point to safety of COVID vaccines, but leave questions unanswered
KARE 11 Minneapolis-St. Paul· 6 hours agoAfter more than 13 billion COVID vaccines given around the world, the largest studies to date point...
Recipients call for help with donations of 'miracle' plasma
BBC via AOL· 1 day agoAnother woman whose life was saved by plasma donations after she was struck by a rare autoimmune...
Annexon, Inc. (NASDAQ:ANNX) Receives $14.43 Average Target Price from Analysts
ETF DAILY NEWS· 6 hours agoShares of Annexon, Inc. (NASDAQ:ANNX – Get Free Report) have received an average rating of “Buy” from the six ratings firms that are covering the company, MarketBeat reports. Six analysts have ...
What Is Postural Hypotension?
Health via Yahoo News· 5 days agoPostural hypotension, or orthostatic hypotension, can make you feel dizzy when you stand up. There are ways to avoid the sudden drop in blood pressure.
8 NFL Draft reaches who paid off for the teams smart enough to pick them, including Josh Allen and...
For The Win· 18 hours agoThese are the guys we laughed at on draft night — only to watch them emerge as Pro Bowlers.
ICI Tx in MS Patients With Comorbid Cancer: Reassuring Data
Medscape· 6 days agoThere is no increased relapse risk in patients with multiple sclerosis and comorbid cancer who are...
Earnings call: Hansa Biopharma reports strong Q1 and optimistic outlook By Investing.com
Investing.com· 6 days agoHansa Biopharma, a leader in enzyme technology for rare immunological conditions, has reported its...
Mock draft: Predicting a full 2024 NFL draft class for the Cowboys
WFAA Dallas-Fort Worth· 3 days agoDALLAS — 2024 NFL draft week has finally arrived, a time that Dallas Cowboys fans have circled on...
MDHHS warns Michigan residents about consuming raw milk amid bird flu outbreak
WXYZ-TV Detroit· 7 days agoThe Michigan Department of Health and Human Services is cautioning residents about the dangers of...
Akari Therapeutics (NASDAQ:AKTX) Now Covered by StockNews.com
ETF DAILY NEWS· 1 day agoResearch analysts at StockNews.com assumed coverage on shares of Akari Therapeutics (NASDAQ:AKTX – Get Free Report) in a research report issued on Wednesday. The brokerage set a “sell” rating ...
